| Sanofi India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500674 |
NSE Symbol : SANOFI |
P/E(TTM) : 33.65 |
|
ISIN Demat : INE058A01010 |
Div & Yield% : 2.32 |
EPS(TTM) : 213.44 |
|
Book Value(₹) : 297.28 |
Market Cap(₹Cr) : 16,541.30 |
Face Value(₹) : 10.00 |
| Particulars | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 2,851.10 | 2,770.10 | 2,956.60 | 2,901.90 | 3,070.60 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 2,851.10 | 2,770.10 | 2,956.60 | 2,901.90 | 3,070.60 |
| Other Income | 83.10 | 203.50 | 563.60 | 89.80 | 94.10 |
| Stock Adjustments | 292.40 | 11.10 | -43.10 | -57.50 | -2.30 |
| Total Income | 3,226.60 | 2,984.70 | 3,477.10 | 2,934.20 | 3,162.40 |
| EXPENDITURE : | |||||
| Raw Materials | 1,493.40 | 1,200.70 | 1,263.70 | 1,196.10 | 1,345.10 |
| Power and Fuel Cost | 14.60 | 14.30 | 13.90 | 23.60 | 42.30 |
| Other Manufacturing Expenses | 75.30 | 74.30 | 73.70 | 90.30 | 77.30 |
| Selling and Administration Expenses | 332.60 | 315.70 | 306.90 | 306.80 | 433.80 |
| Miscellaneous Expenses | 53.00 | 65.90 | 58.90 | 95.40 | 114.10 |
| Employee Benefit Expenses | 370.60 | 405.90 | 433.90 | 460.80 | 449.70 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 887.10 | 907.90 | 1,326.10 | 761.20 | 700.10 |
| Interest | 1.70 | 1.70 | 1.80 | 1.80 | 0.30 |
| Gross Profit | 885.40 | 906.20 | 1,324.30 | 759.40 | 699.80 |
| Depreciation | 39.60 | 41.90 | 66.70 | 82.20 | 99.90 |
| Profit Before Tax | 845.80 | 864.30 | 1,257.60 | 677.20 | 599.90 |
| Current Tax | 243.30 | 245.20 | 336.00 | 211.00 | 227.60 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | -0.70 | -1.50 | -22.80 | -11.40 | -41.90 |
| Reported Net Profit | 603.20 | 620.60 | 944.40 | 477.60 | 414.20 |
| Extraordinary Items | 12.68 | 94.55 | 363.33 | -30.63 | -37.98 |
| Adjusted Net Profit | 590.52 | 526.05 | 581.07 | 508.23 | 452.18 |
| Adjustment below Net Profit | -1.30 | 0.50 | -3.30 | -8.80 | -16.50 |
| Profit/Loss Balance carried down | 843.20 | 1,795.10 | 1,694.60 | 2,029.60 | 1,815.10 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 843.20 | 1,573.00 | 840.60 | 803.80 | 183.20 |
| P & L Balance carried down | 601.90 | 843.20 | 1,795.10 | 1,694.60 | 2,029.60 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 1,670.00 | 5,700.00 | 4,900.00 | 3,650.00 | 3,490.00 |
| Dividend Per Share(Rs) | 167.00 | 570.00 | 490.00 | 365.00 | 349.00 |
| Earnings Per Share-Unit Curr | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| Earnings Per Share(Adj)-Unit Curr | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| Book Value | 441.52 | 554.70 | 967.65 | 921.30 | 1,061.87 |
| Book Value(Adj)-Unit Curr | 441.52 | 554.70 | 967.65 | 921.30 | 1,061.87 |